Thanks Fred for a great find. The game is afoot, indeed. Here are my two fav quotes from the above short segment.
@ 1:04Question: Regarding the German Study that they detected XMRV in the resp tract. Could that lead to another way to diagnose or detect XMRV that is simpler than the way they (WPI) detect it now?
Peterson's reply: I think that’s a very good possibility and that’s clearly being explored.
@
1: 32
Question: Could you say something about Dr Brigitte Huber’s lecture on Monday (In London)
Peterson's reply: ... In which she reported that she used a probe for integrase - specific for XMRV integrase… She is a retrovirologist that used a probe for integrase that is highly specific for the integrase of XMRV and reported from three different cohorts that she found no positives. But again, the question becomes, “How accurate is her probe for integrase? And what populations did she look at?” That’s why we want this idea of sharing specimens because she could (Peterson' emphasis) find XMRV from the positive patient that I showed you. That’s her example from that particular patient – she was positive. But in none of the other patients that she tested.
If she was able to detect a positive control, two questions come to mind. Was her probe sufficiently sensitive/specific to detect lower titres; and were her sample preparation techniques the same as WPI's? I remember Huber stated her sensitivity. But was that enough? Other thoughts?